How Covid-19 vaccine patch could replace jabs
The plastic patches can be self-administered and stored at room temperature
A needle-free Covid-19 vaccine is on track to become a “significant addition” to the global effort to stop the spread, according to scientists.
In a newly published study in the Science Advances journal, Australian researchers say they have developed a 1cm x 1cm skin patch that has been found to be “superior to traditional needle-and-syringe vaccination”.
The “microneedle patch” is a small plastic chip that is “administered with the click of a small, round applicator device” to the upper arm, explained the US-based Smithsonian magazine. The vaccine is then deposited via 5,000 tiny spikes, each about a quarter of a millimetre long.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The spikes are also made of plastic and “are so tiny that they don’t draw blood or trigger the nerve endings that sense pain”, the mag said.
Similar patches are being developed to enable diabetics to administer insulin and could “revolutionise” care, as the BBC reported after the technology was first unveiled in 2018.
Advantages
The University of Queensland team behind the Covid vaccine patch believe it may give greater immune protection than traditional needle injections. Tests on mice found that those treated with the patch developed “more coronavirus antibodies than those injected with the vaccine and were completely protected from getting sick, even with a single dose”, reported New Scientist.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The patch is also a good option for people with a needle phobia – a fear felt by at least one in ten people, according to the NHS.
University of Oxford researchers reported in June that a survey of more than 15,000 UK adults had found that those with an injection phobia were twice as likely to say they were hesitant to get a Covid vaccine.
The patches would also be easier to distribute as they can be stored at room temperature, unlike current Covid vaccines, which have to be refrigerated. Experts hope the patches “could eventually be sent through the mail or even delivered by drones in hard-to-reach places without reliable cold storage”, said Smithsonian mag.
And since the patches can be self-administered, they could be ideal for communities without access to trained medical staff too.
“We wanted to come up with an alternative that would be stable long enough to go that last mile, especially in resource-limited settings,” virologist David Muller, part of the team behind the development, told New Scientist.
Disadvantages
The patch may have some side effects. Smithsonian said that “like any vaccine”, it may “leave your arm feeling sore because it delivers an agent that’s meant to stimulate an immune response”.
The patch “also produces some redness that usually goes away over the course of a few days”, the mag added.
Timeline for roll-out
The Covid-19 patches have only been tested on mice so far. Scientists and Massachusetts-based biotech company Vaxxas, which is manufacturing the patches and applicators, are aiming to begin human trials next year.
Although skin patch vaccines for Covid “may still be a few years away”, said Smithsonian mag, “many experts predict that the coronavirus will become endemic, and it’s possible that booster vaccines will be needed regularly.
“An easy-to-apply, shelf-stable vaccine option could help ensure that more of the world’s population is vaccinated.”
Create an account with the same email registered to your subscription to unlock access.
Kate Samuelson is the newsletter editor, global. She is also a regular guest on award-winning podcast The Week Unwrapped, where she often brings stories with a women’s rights angle. Kate’s career as a journalist began on the MailOnline graduate training scheme, which involved stints as a reporter at the South West News Service’s office in Cambridge and the Liverpool Echo. She moved from MailOnline to Time magazine’s satellite office in London, where she covered current affairs and culture for both the print mag and website. Before joining The Week, Kate worked as the senior stories and content gathering specialist at the global women’s charity ActionAid UK, where she led the planning and delivery of all content gathering trips, from Bangladesh to Brazil. She is passionate about women’s rights and using her skills as a journalist to highlight underrepresented communities.
Alongside her staff roles, Kate has written for various magazines and newspapers including Stylist, Metro.co.uk, The Guardian and the i news site. She is also the founder and editor of Cheapskate London, an award-winning weekly newsletter that curates the best free events with the aim of making the capital more accessible.
-
'Good riddance to the televised presidential debate'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Caitlin Clark the No. 1 pick in bullish WNBA Draft
Speed Read As expected, she went to the Indiana Fever
By Peter Weber, The Week US Published
-
Today's political cartoons - April 16, 2024
Cartoons Tuesday's cartoons - sleepyhead, little people, and more
By The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published